Chargement en cours...
IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
Glioblastoma multiforme is an incurable primary brain tumor. The current standard of care consists of resection followed by radiation and chemotherapy; associated with a median overall survival of 14.6 months. To overcome this dismal outcome, clinicians are turning to immunotherapeutic approaches, w...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692474/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.473 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|